Form 8-K - Current report:
SEC Accession No. 0000950123-02-000644
Filing Date
2002-01-25
Accepted
2002-01-25 00:00:00
Documents
2
Period of Report
2002-01-24
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC y56905e8-k.txt 8-K 3343
3 PRESS RELEASE y56905ex99.txt EX-99 4175
  Complete submission text file 0000950123-02-000644.txt   9286
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 02517004
SIC: 2835 In Vitro & In Vivo Diagnostic Substances